Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

From the New York University Langone Comprehensive Epilepsy Center, New York (O.D.); the University College London Great Ormond Street Institute of Child Health (J.H.C.) and GW Pharmaceuticals (S.W.) — both in London; Lurie Children’s Epilepsy Center, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago (L.L.); the Children’s Hospital of Philadel­ phia, Philadelphia (E.M.); Miami Children’s Hospital, Miami (I.M.); Hôpital Necker– Enfants Malades, Paris (R.N.); Florey Insti­ tute, Austin Health and Royal Children’s Hospital, University of Melbourne, Mel­ bourne, VIC, Australia (I.E.S.); and Massa­ chusetts General Hospital, Boston (E.A.T.). Address reprint requests to Dr. Devinsky at the Department of Neurology, NYU Langone School of Medicine, 223 E. 34th St., New York, NY 10016, or at od4@ nyu . edu.